Table 4.
Diagnostic groups and subgroups | Na | Φb | AAPC (%) | 95% CIc | P‐value |
---|---|---|---|---|---|
Malignant hematopoietic tumors | |||||
Leukemias, myeloproliferative, and myelodysplastic diseases | 7447 | 0.1 | −0.4; 0.7 | 0.64 | |
Acute lymphoid leukemias | 5854 | 0.4 | −0.2; 1.0 | 0.23 | |
Acute myeloid leukemias | 1078 | −0.6 | −2.0; 0.8 | 0.38 | |
Lymphomas | 2832 | −1.1 | −1.9; −0.2 | 0.01 | |
Hodgkin lymphomas | 1262 | −0.3 | −1.6; 0.9 | 0.60 | |
Burkitt lymphomas | 699 | −2.2 | −3.8; −0.5 | 0.01 | |
Other lymphomas | 871 | −1.2 | −2.7; 0.3 | 0.12 | |
CNS tumors | 6359 | 0.4 | −0.1; 1.0 | 0.13 | |
Ependymomas and choroid plexus tumors | 625 | 0.8 | −1.0; 2.6 | 0.39 | |
Embryonal CNS tumors | 1228 | −0.9 | −2.2; 0.4 | 0.17 | |
Gliomasd | 3898 | 1.8 | 0.9 | 0.0; 1.9 | 0.05 |
Pilocytic astrocytomasd | 1409 | 1.8 | −0.6 | −2.0; 0.9 | 0.46 |
Other gliomasd | 2489 | 1.8 | 0.9; 2.7 | <0.01 | |
Embryonal tumors | |||||
Neuroblastomas | 2101 | −0.4 | −1.4; 0.6 | 0.40 | |
Retinoblastomas | 742 | −0.7 | −2.4; 0.9 | 0.40 | |
Nephroblastomas | 1415 | −0.1 | −1.3; 1.2 | 0.93 | |
Hepatoblastomas | 218 | 1.9 | −1.2; 5.1 | 0.23 | |
Malignant bone and soft tissue tumors | |||||
Malignant bone tumors | 1225 | −0.4 | −1.7; 0.9 | 0.53 | |
Osteosarcomasd | 576 | 1.6 | −0.9 | −3.1; 1.3 | 0.43 |
Ewing tumors | 556 | 0.7 | −1.2; 2.7 | 0.47 | |
Soft tissue and other extraosseous sarcomas | 1654 | −0.1 | −1.2; 1.0 | 0.80 | |
Rhabdomyosarcomas | 899 | 0.1 | −1.4; 1.6 | 0.88 | |
Other soft tissue sarcomas | 755 | −0.5 | −2.1; 1.2 | 0.59 | |
Germ‐cell tumors, trophoblastic tumors, and neoplasms of gonads | 836 | −1.9 | −3.4; −0.3 | 0.02 | |
Intracranial and intraspinal GCT | 229 | −1.2 | −4.1; 1.8 | 0.42 | |
Malignant extracranial and extragonadal GCTe | 263 | 1.7 | −1.9 | −5.1; 1.4 | 0.25 |
Malignant gonadal germ cell tumors | 318 | −2.6 | −5.0; −0.1 | 0.04 | |
Boyse | 110 | −5.4 | −9.4; −1.1 | 0.01 | |
Girlse | 208 | −1.1 | −4.1; 2.1 | 0.51 | |
All cancers | 25 877 | −0.1 | −0.3; 0.2 | 0.69 |
AAPC: average annual percent change; CNS, Central Nervous System; GCT, Germ Cell Tumors.
Results have to be interpreted with caution.
Number of cases.
Φ: degree of overdispersion estimated by the ratio of the deviance of the Poisson regression model to the number of degrees of freedom.
Average annual Percent Change and the 95% confidence interval estimated with a Poisson regression model.
Binomial negative model.
Less than 15 cases per year on average.